MAEYAMA Jun-ichi | Dept. of Safety Research on Biologics, National Institute of Infectious Diseases
スポンサーリンク
概要
関連著者
-
Yasuda Yoko
Department Of Bacteriology Nagoya City University Graduate School Of Medical Sciences
-
Kozuka Satoshi
Department Of Microbiology Nagoya City University Medical School
-
GOTO Norihisa
Dept. of Safety Res. on Biologics, National Institute of Infectious Disdases
-
Goto Norihisa
Department Of Safety Research On Blood And Biological Products
-
Tochikubo Kunio
Department Of Bacteriology Nagoya City University Graduate School Of Medical Sciences
-
Isaka Masanori
Department Of Bacteriology Nagoya City University Graduate School Of Medical Sciences
-
TANIGUCHI Tooru
Department of Microbiology, Nagoya City University Medical School
-
Taniguchi Tooru
Department Of Microbiology Nagoya City University Medical School
-
MAEYAMA Jun-ichi
Dept. of Safety Research on Biologics, National Institute of Infectious Diseases
-
ISAKA Masanori
Dept. of Microbiology, Nagoya City University Medical School
-
TANIGUCHI Tooru
Dept. of Microbiology, Nagoya City University Medical School
-
KOZUKA Satoshi
Dept. of Microbiology, Nagoya City University Medical School
-
YASUDA Yoko
Dept. of Microbiology, Nagoya City University Medical School
-
TOCHIKUBO Kunio
Dept. of Microbiology, Nagoya City University Medical School
-
Taniguchi Taketoshi
Laboratory Of Molecular Biology Medical Research Center Kochi Medical School
-
Maeyama Jun-ichi
Department Of Safety Research On Blood And Biological Products National Institute Of Infectious Dise
-
MATANO Keiko
Department of Microbiology, Nagoya City University Medical School
-
MATANO Keiko
Dept.of Microbiology, Nagoya City University Medical School
-
MIURA Yutaka
Dept.of Microbiology, Nagoya City University Medical School
-
Matano Keiko
Department Of Microbiology Nagoya City University Medical School
-
Miura Yutaka
Dept.of Microbiology Nagoya City University Medical School
著作論文
- O-25 Adjuvanticity and Safety of rCTB as a Nasal Mucosal Adjuvant.(Proceedings of the 27th Annual Meeting)
- Evaluation of Recombinant Cholera Toxin B Subunit as a Nasal Mucosal Adjuvant.